Common disorder linked to 70% higher death rate, but medication may offer protection

EXECUTIVE SUMMARY

A major new global review reveals that adults diagnosed with ADHD face a 71% higher mortality risk, but prescription treatments offer crucial protection.

Doctor breaks down ADHD's potential connection to dementia and cognitive decline

People diagnosed with attention-deficit/hyperactivity disorder (ADHD) face a roughly 71% higher overall risk of early death compared to those without the condition, according to a new review published in JAMA Network Open.

However, taking prescription ADHD medication may offer a protective benefit, lowering overall risk of death, the review found.